Research Topics
Genomes and GenesSpecies | P ScheltensSummaryAffiliation: VU University Medical Center Country: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trialPhilip Scheltens
Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
J Alzheimers Dis 31:225-36. 2012..EEG outcomes suggest that Souvenaid has an effect on brain functional connectivity, supporting the underlying hypothesis of changed synaptic activity...
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light--a randomized clinical trialEls I S Most
Netherlands Institute for Neuroscience, an institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam, The Netherlands
Trials 11:19. 2010....
Visual assessment of posterior atrophy development of a MRI rating scaleEsther L G E Koedam
Department of Neurology and Alzheimer Centre, VU University Medical Centre, PO Box 7057, 1007 MB, Amsterdam, The Netherlands
Eur Radiol 21:2618-25. 2011..To develop a visual rating scale for posterior atrophy (PA) assessment and to analyse whether this scale aids in the discrimination between Alzheimer's disease (AD) and other dementias...
Functional neural network analysis in frontotemporal dementia and Alzheimer's disease using EEG and graph theoryWillem de Haan
Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
BMC Neurosci 10:101. 2009..All results were normalized for network size and compared with random control networks...
(Cost)-effectiveness of family meetings on indicated prevention of anxiety and depressive symptoms and disorders of primary family caregivers of patients with dementia: design of a randomized controlled trialKarlijn J Joling
Department of General Practice, Institute for Research in Extramural Medicine, VU University Medical Center, Amsterdam, The Netherlands
BMC Geriatr 8:2. 2008....
Can novel therapeutics halt the amyloid cascade?Niels D Prins
Alzheimer Center, VU University Medical Center, Boelelaan 1118, Amsterdam, The Netherlands
Alzheimers Res Ther 2:5. 2010..However, it may also be that these negative findings reflect our still incomplete understanding of, at least part of, the pathogenesis of Alzheimer's disease...
Imaging in Alzheimer's diseasePhilip Scheltens
Dept Neurology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Dialogues Clin Neurosci 11:191-9. 2009..In this review, the various imaging techniques will be highlighted, with an emphasis on their ability to diagnose Alzheimer's disease and separate it from other entities...
Moving forward with nutrition in Alzheimer's diseaseP Scheltens
Department of Neurology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Eur J Neurol 16:19-22. 2009..The Souvenir study is the first randomized, controlled, double-blind, multi-centre study designed to evaluate the efficacy of a multi-nutrient dietary approach on cognitive performance in drug-naïve early AD patients...
Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trialPhilip Scheltens
VU University Medical Center, Amsterdam, The Netherlands
Alzheimers Dement 6:1-10.e1. 2010..To investigate the effect of a medical food on cognitive function in people with mild Alzheimer's disease (AD)...
White-matter changes on MRI as surrogate markerPhilip Scheltens
Department of Neurology, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands
Int Psychogeriatr 15:261-5. 2003....
Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusionPhilip Scheltens
Department of Neurology and Alzheimer Centre, Vrije Universiteit Medical Centre, Amsterdam, Netherlands
Lancet Neurol 1:13-21. 2002..Imaging research is also likely to focus on measuring progression and detecting therapeutic effect. As such, MRI is already become an indispensable tool in clinical trials in dementia...
How golden is the gold standard of neuropathology in dementia?Philip Scheltens
Department of Neurology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Alzheimers Dement 7:486-9. 2011..As an alternative, we propose to abandon thinking in standards and value neuropathology as any other biomarker, and to strive to use and integrate multiple sources of information to make the diagnosis of AD in all its complexity...
All patients with suspected dementia should be scanned at least once with CT or MRIPhilip Scheltens
Department of Neurology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Int Psychogeriatr 19:533-4; discussion 534-8. 2007
Structural neuroimaging outcomes in clinical dementia trials, with special reference to disease modifying designsP Scheltens
Dept Neurology and Alzheimer Center VU University Medical Center
J Nutr Health Aging 10:123-8; discussion 129-30. 2006....
Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer diseaseW J P Henneman
Department of Radiology and Alzheimer Center, VU University Medical Center, 1007 MB Amsterdam, The Netherlands
Neurology 73:935-40. 2009....
Baseline predictors of rates of hippocampal atrophy in mild cognitive impairmentL A van de Pol
Department of Neurology, Alzheimer Centre, VU Medical Centre, Amsterdam, The Netherlands
Neurology 69:1491-7. 2007..We compared baseline clinical, neuropsychological, and MRI measures to characterize these MCI subgroups...
New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic populationF H Bouwman
Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
Dement Geriatr Cogn Disord 30:1-7. 2010..This study applies the criteria in a memory clinic population, using clinical criteria as the reference criterion...
Whole-brain atrophy rate in Alzheimer disease: identifying fast progressorsJ D Sluimer
Department of Radiology and Alzheimer Centre, Vrije Universiteit Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Neurology 70:1836-41. 2008..To assess which baseline clinical and MRI measures influence whole-brain atrophy rates, measured from serial MR imaging...
CSF biomarkers predict rate of cognitive decline in Alzheimer diseaseM I Kester
Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
Neurology 73:1353-8. 2009..We hypothesized that high tau, especially in combination with relatively low p-tau-181, is a marker of rapid decline, since it has been associated with fast neuronal degeneration...
CSF biomarkers in relationship to cognitive profiles in Alzheimer diseaseA E van der Vlies
Department of Neurology and Alzheimer Center, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Neurology 72:1056-61. 2009..To investigate the relationship between CSF biomarkers and cognitive profiles in Alzheimer disease (AD)...
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohortN S M Schoonenboom
Departments of Neurology, VU University Medical Center, Alzheimer Center, Amsterdam, The Netherlands
Neurology 78:47-54. 2012..To determine how amyloid β 42 (Aβ42), total tau (t-tau), and phosphorylated tau (p-tau) levels in CSF behave in a large cohort of patients with different types of dementia...
Distribution of APOE genotypes in a memory clinic cohortW M van der Flier
Alzheimer Center, Department of Neurology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Dement Geriatr Cogn Disord 25:433-8. 2008..To describe the distribution of apolipoprotein E (APOE) genotypes in a cohort of memory clinic patients...
CSF biomarkers in frontotemporal lobar degeneration: relations with clinical characteristics, apolipoprotein E genotype, and neuroimagingY A L Pijnenburg
Alzheimer Center, Department of Neurology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 77:246-8. 2006..CSF Abeta42 variability remained unexplained. Future research could study the role of ApoE genotype and Abeta42 in FTLD, as well as establish measures for disease intensity...
Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measuresW J P Henneman
Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands
Neurology 72:999-1007. 2009..To investigate the added value of hippocampal atrophy rates over whole brain volume measurements on MRI in patients with Alzheimer disease (AD), patients with mild cognitive impairment (MCI), and controls...
Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer's diseaseC J Stam
Department of Clinical Neurophysiology and MEG, Amsterdam, The Netherlands
Brain 132:213-24. 2009..The modelling results suggest that highly connected neural network 'hubs' may be especially at risk in Alzheimer's disease...
Prevalence and severity of microbleeds in a memory clinic settingC Cordonnier
Department of Neurology, Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Neurology 66:1356-60. 2006..This finding of a relatively high proportion of MBs in Alzheimer disease and mild cognitive impairment provides further evidence for the involvement of vascular factors in neurodegenerative diseases such as Alzheimer disease...
Anterior medial temporal lobe activation during attempted retrieval of encoded visuospatial scenes: an event-related fMRI studyS A Rombouts
Department of Clinical Physics and Informatics, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Neuroimage 14:67-76. 2001..We conclude that the left posterior parahippocampal gyrus responds during encoding, while on the other hand the left anterior parahippocampal gyrus and the right anterior hippocampus were more strongly involved in retrieval...
Neurological signs in relation to white matter hyperintensity volumes in memory clinic patientsS S Staekenborg
Department of Neurology and Alzheimer Center, Vrije Universiteit Medical Center, Amsterdam, The Netherlands s staekenborg vumc nl
Dement Geriatr Cogn Disord 29:301-8. 2010..To determine the frequency of neurological signs in a memory clinic population and to explore their associations with white matter hyperintensity (WMH)...
Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS studyE S C Korf
Alzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
Diabet Med 24:166-71. 2007....
Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onsetA E van der Vlies
Department of Neurology and Alzheimer Centre, VU University Medical Centre, Amsterdam, The Netherlands
Psychol Med 39:1907-11. 2009..We aimed to compare the rate of cognitive decline in patients with early and late onset Alzheimer's disease (AD) and to investigate the potentially modifying influence of the apolipoprotein E (APOE) genotype...
Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progressionA A Gouw
Alzheimer Center, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Cerebrovasc Dis 25:247-53. 2008..However, the most suitable method for measuring WMH progression has not been established yet. We compared the reliability and sensitivity of cross-sectional and longitudinal visual scales with volumetry for measuring WMH progression...
CSF tau and Abeta42 are not useful in the diagnosis of frontotemporal lobar degenerationY A L Pijnenburg
Alzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
Neurology 62:1649. 2004
Improved reliability of hippocampal atrophy rate measurement in mild cognitive impairment using fluid registrationL A van de Pol
Department of Neurology, Alzheimer Centre, VU Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Neuroimage 34:1036-41. 2007..This method may be useful to quantify hippocampal volume change, given the reduction in operator time and improved precision...
White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA studyL A van de Pol
VUMC, Department of Neurology, Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 80:1069-74. 2009..Clinical subtypes of mild cognitive impairment (MCI) may represent different underlying aetiologies...
Longitudinal changes of CSF biomarkers in memory clinic patientsF H Bouwman
Alzheimer Center and Department of Neurology, VU Medical Center, Amsterdam, The Netherlands
Neurology 69:1006-11. 2007..We evaluated the natural course of CSF biomarkers in patients with AD, subjective complaints, and mild cognitive impairment (MCI)...
EEG functional connectivity and ApoE genotype in Alzheimer's disease and controlsGerdien Kramer
Department of Neurology, Alzheimer Centre, VU University Medical Center, PO Box 7057, De Boelelaan 1118, 1007 MB Amsterdam, Noord Holland, The Netherlands
Clin Neurophysiol 119:2727-32. 2008....
Profile of cognitive impairment in chronic heart failureRaymond L C Vogels
Department of Neurology, Sint Lucas Andreas Hospital, Amsterdam, The Netherlands
J Am Geriatr Soc 55:1764-70. 2007..To determine the frequency and pattern of cognitive dysfunction in outpatients with chronic congestive heart failure (CHF) and to identify the corresponding demographic and clinical correlates...
Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer's diseaseC Mulder
Department of Clinical Chemistry, VU University Medical Center, Amsterdam, The Netherlands
J Neural Transm 110:949-55. 2003....
White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter ChangesP Scheltens
Department of Neurology, Academisch Ziekenhuis VU, Amsterdam, The Netherlands
Eur Neurol 39:80-9. 1998..The ideal rating scale does not yet exist, but different rating scales may serve different purposes, for which some recommendations are made...
The use of EEG in the diagnosis of dementia with Lewy bodiesG Roks
Alzheimer Center, VU University Medical Center, Department of Neurology, Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 79:377-80. 2008..9% of the patients with AD and in 33.3% of the patients with DLB. The GTE is a simple EEG scoring method that can be helpful in the differential diagnosis between DLB and AD with good sensitivity and specificity...
Hippocampal atrophy in Alzheimer disease: age mattersL A van de Pol
Department of Neurology, Alzheimer Center, VU Medical Center, Amsterdam, The Netherlands
Neurology 66:236-8. 2006..Aging and AD were independently associated with smaller hippocampal volume. Both young and old AD patients have hippocampal atrophy abnormal for age. Age-dependent criteria for hippocampal atrophy, suggestive of AD, are needed...
Attention modulates hemispheric differences in functional connectivity: evidence from MEG recordingsLiselotte Gootjes
Department of Clinical Neuropsychology, Vrije Universiteit, Amsterdam, The Netherlands
Neuroimage 30:245-53. 2006..This supports the idea of a supervisory role for the frontal cortex in attention processes...
Model-free group analysis shows altered BOLD FMRI networks in dementiaSerge A R B Rombouts
Department of Physics and Medical Technology, Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Hum Brain Mapp 30:256-66. 2009..The technique is more sensitive than the commonly applied model-based method. Consistent with other research, we show that networks of activation and deactivation show decreased reactivity in dementia...
Diagnostic accuracy of consensus diagnostic criteria for frontotemporal dementia in a memory clinic populationYolande A L Pijnenburg
Alzheimer Centre, VU University Medical Centre, Amsterdam, The Netherlands
Dement Geriatr Cogn Disord 25:157-64. 2008..The goal of the present study was to evaluate the diagnostic accuracy of the core diagnostic criteria for frontotemporal dementia (FTD) [Neary D, et al: Neurology 1998;51:1546-1554] within a memory clinic population...
Disrupted modular brain dynamics reflect cognitive dysfunction in Alzheimer's diseaseW de Haan
Department of Clinical Neurophysiology and MEG, VU University Medical Center, Amsterdam, The Netherlands
Neuroimage 59:3085-93. 2012..These findings imply the relevance of regarding dementia as a functional network disorder...
Loss of frontal fMRI activation in early frontotemporal dementia compared to early ADS A R B Rombouts
Department of Neurology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Neurology 60:1904-8. 2003..To compare frontal cortex activation in patients with early frontotemporal dementia (FTD) with that in patients with early AD...
The effect of anxiety and depression on decline of memory function in Alzheimer's diseaseE J M Bierman
Department of Psychiatry, EMGO Institute, VU Medical Centre, Amsterdam, The Netherlands
Int Psychogeriatr 21:1142-7. 2009..The present study investigated whether symptoms of anxiety and depression predict decline of memory function in elderly people diagnosed with early stage AD...
Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's diseaseL A van de Pol
VUMC, Department of Neurology, PO Box 7057, 1007 MB Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 77:439-42. 2006..Hippocampal atrophy on magnetic resonance imaging (MRI) is an early characteristic of Alzheimer's disease. However, hippocampal atrophy may also occur in other dementias, such as frontotemporal lobar degeneration (FTLD)...
Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitusG J Biessels
The Alzheimer Center, Department of Neurology, VU Medical Center, Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 77:304-7. 2006..The risk of Alzheimer's disease (AD) is increased in type 2 diabetes (DM2). This increased risk has been attributed to vascular comorbidity, but other mechanisms, such as accelerated ageing of the brain, have also been implicated...
Magnetoencephalographic analysis of cortical activity in Alzheimer's disease: a pilot studyH W Berendse
Department of Clinical Neurophysiology, Research Institute Neurosciences VU, University Hospital Vrije Universiteit, Amsterdam, Netherlands
Clin Neurophysiol 111:604-12. 2000..In the present study, MEG was used to analyze spectral power and reference-free coherence in patients with probable Alzheimer's disease (AD)...
Differential association of [11C]PIB and [18F]FDDNP binding with cognitive impairmentN Tolboom
Department of Nuclear Medicine and PET Research, VU University Medical Centre, Amsterdam, The Netherlands
Neurology 73:2079-85. 2009....
Head trauma and Alzheimer's diseaseRishi D S Nandoe
Department of Neurology, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands
J Alzheimers Dis 4:303-8. 2002..Extensive history taking disclosed no cognitive changes prior to the car accident. The case is discussed in view of the inflammation hypothesis regarding Alzheimer's disease and the role of the apolipoprotein E4 genotype of the patient...
Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI studyRutger Goekoop
Department of Neurology Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Brain 129:141-57. 2006....
The auditory oddball paradigm in patients with vascular cognitive impairment: a prolonged latency of the N2 complexB van Harten
Department of Neurology, Sint Lucas Andreas Hospital, Amsterdam, The Netherlands
Dement Geriatr Cogn Disord 21:322-7. 2006..The aim of this study was to investigate the diagnostic value of the different elements of this response (N(1), N(2) complex and P(3) latencies) in a group of elderly patients with VCI caused by SIVD...
The effect of APOE genotype on clinical phenotype in Alzheimer diseaseW M van der Flier
Department of Neurology and Alzheimer Center, Vrije Universiteit Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Neurology 67:526-7. 2006..2 to 7.8), suggesting that two subtypes of AD can be identified. The typical amnestic phenotype seems to be promoted by the APOE-epsilon4 allele, whereas the atypical nonmemory phenotype occurs in the absence of the APOE-epsilon4 allele...
No evidence for increased self-reported cognitive failure in Type 1 and Type 2 diabetes: a cross-sectional studyA M Wessels
Department of Medical Psychology, VU University Medical Centre, Amsterdam, The Netherlands
Diabet Med 24:735-40. 2007..This study set out to investigate the magnitude and correlates of self-reported cognitive failure in adult out-patients with Type 1 and Type 2 diabetes...
Associations between patterns of EEG abnormalities and diagnosis in a large memory clinic cohortM Liedorp
Alzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
Dement Geriatr Cogn Disord 27:18-23. 2009..To describe associations of abnormalities in the electroencephalogram (EEG) with the most prevalent diagnoses in a memory clinic cohort...
Nonlinear changes in brain activity during continuous word repetition: an event-related multiparametric functional MR imaging studyR E Hagenbeek
Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands
AJNR Am J Neuroradiol 28:1715-21. 2007..Our aim was to identify linear changes in brain activation and, what is more interesting, nonlinear changes in brain activation as a function of extended word repetition...
Small vessel versus large vessel vascular dementia: risk factors and MRI findingsS S Staekenborg
Dept of Neurology and Alzheimer Centre, Vrije Universiteit Medical Centre, 7057, 1007 MB Amsterdam, The Netherlands
J Neurol 255:1644-51; discussion 1813-4. 2008....
Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathologyA A Gouw
Department of Neurology, Alzheimer Center and Image Analysis Center, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Brain 131:3286-98. 2008..Quantitative MRI techniques reveal differences in WMH between Alzheimer's disease and non-demented elderly, and are able to reflect the severity of the neuropathological changes involved...
Validation of the HIV Dementia Scale in an elderly cohort of patients with subcortical cognitive impairment caused by subcortical ischaemic vascular disease or a normal pressure hydrocephalusBarbera van Harten
Department of Neurology, Sint Lucas Andreas Hospital, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands
Dement Geriatr Cogn Disord 18:109-14. 2004..Materials and..
The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementiaAntonio J Bastos-Leite
Image Analysis Center, VU University Medical Center, Amsterdam, The Netherlands
Stroke 38:3182-5. 2007..Therefore, our purpose was to investigate the relative contribution of cerebrovascular disease and MTA to cognitive impairment in patients fulfilling diagnostic criteria for VaD...
Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutationsSonia M Rosso
Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands
Arch Neurol 60:1209-13. 2003..Mutations in the tau gene have been found in the familial form of FTD, linked to chromosome 17q21-22, showing a spectrum of tauopathy...
Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based studySonia M Rosso
Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands
Brain 126:2016-22. 2003..The finding of tau mutations in 32% of patients with a positive family history for dementia justifies mutation screening in FTD patients with a positive family history, while tau mutations in non-familiar cases are rare...
Whole brain analysis of T2* weighted baseline FMRI signal in dementiaSerge A R B Rombouts
Department of Physics and Medical Technology, Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
Hum Brain Mapp 28:1313-7. 2007..We conclude that in FMRI studies of dementia, not only the dynamic BOLD signal (activation and deactivation) but also the average baseline signal is diminished in certain regions. The method we applied may also be used in task-rel..
Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer diseaseCees Mulder
Department of Clinical Chemistry, VU University Medical Center, Alzheimer Center, Amsterdam, The Netherlands
Clin Chem 56:248-53. 2010..We have used these markers and evaluated their performance...
Global and local gray matter loss in mild cognitive impairment and Alzheimer's diseaseG B Karas
Department of Diagnostic Radiology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Neuroimage 23:708-16. 2004..Mild cognitive impairment (MCI) is thought to be the prodromal phase to Alzheimer's disease (AD). We analyzed patterns of gray matter (GM) loss to examine what characterizes MCI and what determines the difference with AD...
Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer diseaseG Karas
Department of Diagnostic Radiology, VU University Medical Center, Amsterdam, The Netherlands
AJNR Am J Neuroradiol 29:944-9. 2008..We used voxel-based morphometry (VBM) to find out whether structural differences on MR imaging could offer insight into the development of clinical AD in patients with amnestic MCI at 3-year follow-up...
Unbiased whole-brain analysis of gray matter loss in Alzheimer's diseaseS A Rombouts
Department of Clinical Physics and Informatics, University Hospital Vrije Universiteit, P O Box 7057, 1007 MB, Amsterdam, The Netherlands
Neurosci Lett 285:231-3. 2000..The exact role of these two structures in the symptomatology of Alzheimer's disease deserves further attention...
Hippocampal sulcus width and cavities: comparison between patients with Alzheimer disease and nondemented elderly subjectsA J Bastos-Leite
Department of Radiology and Image Analysis Center, VU University Medical Center, Amsterdam, The Netherlands
AJNR Am J Neuroradiol 27:2141-5. 2006..We hypothesized that either hippocampal sulcus enlargement or an increase in number or size of hippocampal cavities could be associated with medial temporal lobe atrophy (MTA) occurring in Alzheimer disease...
Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensitiesA J Bastos-Leite
Image Analysis Center, VU University Medical Center, Amsterdam, The Netherlands
AJNR Am J Neuroradiol 29:1296-301. 2008..We hypothesized that elderly subjects with diffuse confluent WMH should have lower cerebral blood flow (CBF) measurements than subjects with punctiform or beginning confluent WMH...
Evaluation of reference regions for (R)-[(11)C]PK11195 studies in Alzheimer's disease and mild cognitive impairmentMarc A Kropholler
Department of Nuclear Medicine and PET Research, VU University Medical Centre, Amsterdam, The Netherlands
J Cereb Blood Flow Metab 27:1965-74. 2007..Most anatomic regions outperformed cluster analysis in terms of absence of both scan rejection and bias. Total cerebellum is the optimal reference region in this patient category...
Raloxifene treatment enhances brain activation during recognition of familiar items: a pharmacological fMRI study in healthy elderly malesRutger Goekoop
Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
Neuropsychopharmacology 31:1508-18. 2006..Behaviorally, such neurofunctional effects may actively block decreased memory performance as a result of context-dependency. The validity of these predictions can be tested in large-scale clinical trials...
Diabetes and cognitive impairment. Clinical diagnosis and brain imaging in patients attending a memory clinicGeert Jan Biessels
Department of Neurology, G03 228, University Medical Center Utrecht, 85500, 3508 GA, Utrecht, The Netherlands
J Neurol 253:477-82. 2006....
Use of laboratory and imaging investigations in dementiaW M van der Flier
Department of Neurology and Alzheimer Center, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 76:v45-52. 2005
Cognitive slowing in multiple sclerosis is strongly associated with brain volume reductionR H C Lazeron
Department of Neurology, Vrije Universiteit Medical Center, P O Box 7057, 1007 MB Amsterdam, The Netherlands
Mult Scler 12:760-8. 2006..Since MS is characterized by cognitive slowing rather than impaired accuracy, we used the Amsterdam Neuropsychological Tasks (ANT) program, a computerized test proven to be very sensitive to cognitive slowing in MS patients...
Consistent resting-state networks across healthy subjectsJ S Damoiseaux
Department of Neurology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
Proc Natl Acad Sci U S A 103:13848-53. 2006..These findings show that the baseline activity of the brain is consistent across subjects exhibiting significant temporal dynamics, with percentage BOLD signal change comparable with the signal changes found in task-related experiments...
Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled studyW A van Gool
Department of Neurology, Academic Medical Centre, PO Box 22700, 1100 DE, Amsterdam, Netherlands
Lancet 358:455-60. 2001..We aimed to establish the effect of the anti-inflammatory drug hydroxychloroquine on the progression of dementia...
Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS studyW M van der Flier
Department of Neurology and Alzheimer Centre, Vrije Universiteit Medical Centre, 1007 MB Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 76:1497-500. 2005..To assess the associations of medial temporal lobe atrophy (MTA) and white matter hyperintensities (WMH) with cognitive function in a large group of independently functioning elderly people...
The diagnostic value of electroencephalography in mild senile Alzheimer's diseaseJ J Claus
Department of Neurology, Academic Medical Centre, Amsterdam, The Netherlands
Clin Neurophysiol 110:825-32. 1999..We investigated the diagnostic value of the visually assessed electroencephalogram (EEG) in patients with mild Alzheimer's disease (AD), using the grand total of EEG (GTE) score...
Alzheimer's disease is not associated with altered concentrations of the nitric oxide synthase inhibitor asymmetric dimethylarginine in cerebrospinal fluidC Mulder
Department of Clinical Chemistry, VU University Medical Center, Amsterdam, The Netherlands, Sweden
J Neural Transm 109:1203-8. 2002..Our results suggest that in early stages of AD overall regulation of NO production by ADMA is not aberrant...
Efficacy of a medical food on cognition in Alzheimer's disease: results from secondary analyses of a randomized, controlled trialP J G H Kamphuis
Nutricia Advanced Medical Nutrition, Danone Research, Centre for Specialised Nutrition, Wageningen, The Netherlands
J Nutr Health Aging 15:720-4. 2011..0) and patients with 'high' baseline ADAS-cog scores (≥25.0). Repeated Measures Models (RMM) were used to determine the relationship between ADAS-cog score and intervention...
Effect of a medical food on body mass index and activities of daily living in patients with Alzheimer's disease: secondary analyses from a randomized, controlled trialP J G H Kamphuis
Nutricia Advanced Medical Nutrition, Danone Research, Centre for Specialised Nutrition, Wageningen, The Netherlands
J Nutr Health Aging 15:672-6. 2011..Both ADCS-ADL and BMI were assessed at baseline and Weeks 6, 12 and 24. Data were analyzed using a repeated-measures mixed model...
Effects of transcutaneous electrical nerve stimulation (TENS) on non-pain related cognitive and behavioural functioningKoene R A van Dijk
Department of Clinical Neuropsychology, Vrije Universiteit, Amsterdam, The Netherlands
Rev Neurosci 13:257-70. 2002..It is argued that arousal may underlie the beneficial influence of TENS in various conditions. Finally, suggestions are offered for future research...
Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging StudyEsther S C Korf
Department of Neurology and Alzheimer Center, Universiteit Medical Center, Amsterdam, The Netherlands
Hypertension 44:29-34. 2004..51; CI=1.26; 9.74). In conclusion, treatment with antihypertensive treatment modifies the association of BP and HA, such that high levels of BP adversely affect the hippocampus in persons never treated with antihypertensives...
Evaluation of methods for generating parametric (R-[11C]PK11195 binding imagesAlie Schuitemaker
Department of Nuclear Medicine and PET Research, VU University Medical Centre, Amsterdam, The Netherlands
J Cereb Blood Flow Metab 27:1603-15. 2007..In pathological conditions with reduced flow rates or large variations in blood volume, the basis function method is preferred because it produces less bias and is more precise...
Emerging treatments in dementiaP Scheltens
Department of Neurology, Academisch Ziekenhuis VU, Amsterdam, The Netherlands
Eur Neurol 38:184-9. 1997..The question of heterogeneity may be solved when different therapeutic strategies are found for different subtypes. The focus of future plans should be on preventive strategies combined with an early diagnosis...
A systematic review of Instrumental Activities of Daily Living scales in dementia: room for improvementS A M Sikkes
Department of Epidemiology and Biostatistics, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 80:7-12. 2009..Despite the large number of questionnaires, their quality has received little attention...
Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathyA M Wessels
Department of Medical Psychology, VU University Medical Center, Van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands
Diabetologia 49:2474-80. 2006..The aim of our study was to use magnetic resonance imaging (MRI) to establish whether long-term hyperglycaemia, resulting in advanced retinopathy, contributes to structural changes in the brain (reduced grey matter)...
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's diseaseN A Verwey
Department of Clinical Chemistry, VU University Medical Center, HV, The Netherlands
Ann Clin Biochem 46:235-40. 2009..The aim of this study was to compare the measurements of these CSF biomarkers, between and within centres...
Magnetoencephalographic evaluation of resting-state functional connectivity in Alzheimer's diseaseC J Stam
Department of Clinical Neurophysiology and MEG, VU University Medical Center, P O Box 7057, 1007 MB Amsterdam, The Netherlands
Neuroimage 32:1335-44. 2006..These changes may reflect loss of anatomical connections and/or reduced central cholinergic activity and could underlie part of the cognitive impairment...
Decreased cerebrospinal fluid amyloid beta (1-40) levels in frontotemporal lobar degenerationY A L Pijnenburg
Alzheimer Centre and Department of Neurology, VU University Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 78:735-7. 2007..These findings favour a differential involvement of amyloid beta peptides in FTLD compared with AD...
Epidemiology and risk factors of dementiaW M van der Flier
Department of Neurology and Alzheimer Center, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 76:v2-7. 2005
The significance of medial temporal lobe atrophy: a postmortem MRI study in the very oldF Barkhof
Department of Radiology, VU University Medical Centre, P O Box 7057, 1007 MB Amsterdam, The Netherlands
Neurology 69:1521-7. 2007..Medial temporal lobe atrophy (MTA) is a sensitive radiologic marker for Alzheimer disease (AD) and associated with cognitive impairment. The value of MTA in the oldest old (>85 years old) is largely unknown...
[The immune system and Alzheimer's disease]E van Exel
VUMC GGZ inGeest, Amsterdam
Tijdschr Psychiatr 53:637-43. 2011..It has still not been established unequivocally whether vascular risk factors and inflammatory reactions, determined by heredity, are a cause or a result of Alzheimer's disease..
Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volumeA M Wessels
Department of Medical Psychology, VU University Medical Centre, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands
Diabetologia 50:1763-9. 2007....
Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's diseaseS A R B Rombouts
Department of Neurology Alzheimer Centre, Vrije Universiteit Medical Centre, Amsterdam, Netherlands
J Neurol Neurosurg Psychiatry 73:665-71. 2002..It remains unclear where in the brain it exerts its effect. Functional magnetic resonance imaging (fMRI) can be used to measure changes in brain function and relate these to cognition...
Radiotherapy-induced cerebral abnormalities in patients with low-grade gliomaT J Postma
Department of Neurology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
Neurology 59:121-3. 2002..White matter abnormalities were observed in six patients, all of whom were treated with prior radiotherapy. These radiologic cerebral abnormalities correlated with cognitive performance...
Accelerating regional atrophy rates in the progression from normal aging to Alzheimer's diseaseJasper D Sluimer
Department of Diagnostic Radiology, VU University Medical Centre, Amsterdam, The Netherlands
Eur Radiol 19:2826-33. 2009..Finally, in nondemented elderly, medial temporal lobe atrophy was most predictive of progression to AD, demonstrating the involvement of this region in the development of AD...
Medial temporal lobe atrophy and APOE genotype do not predict cognitive improvement upon treatment with rivastigmine in Alzheimer's disease patientsPieter Jelle Visser
Department of Neurology, Alzheimer Centre, VU Medisch Centrum, Amsterdam, The Netherlands
Dement Geriatr Cogn Disord 19:126-33. 2005..Only a subgroup of subjects with probable AD shows cognitive improvement after treatment with cholinesterase inhibitors...
Differences and similarities between two frequently used assays for amyloid beta 42 in cerebrospinal fluidNiki S M Schoonenboom
Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
Clin Chem 51:1057-60. 2005
